CLS Holdings USA, Inc. Announces New Brand Manager, Dani Baranowski, for The Company’s Branded Division, City Trees

3 years ago

LAS VEGAS, NV / ACCESSWIRE / December 7, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a…

Innovation Pharmaceuticals Analyzing Full Dataset for Its Brilacidin COVID-19 Clinical Trial; Company Evaluating New Pipeline Opportunities for 2022

3 years ago

WAKEFIELD, MA / ACCESSWIRE / December 7, 2021 / Innovation Pharmaceuticals (OTCQB:IPIX) ("the Company"), a clinical stage biopharmaceutical company, today…

Nemaura Medical Completes Initial Shipment of CGM Devices to UK Licensee

3 years ago

Sales in UK expected to be followed by launches across major EU territories in 2022 Loughborough, England, Dec. 07, 2021…

PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases

3 years ago

Collaboration aims to identify variants not easily detectible by short-read sequencing, increasing diagnostic yield in rare disease patientsMENLO PARK, Calif.,…

Sorrento Therapeutics’ Clinical Laboratory Receives Accreditation From the College of American Pathologists

3 years ago

Sorrento has received accreditation from the American College of Pathologists, which allows Sorrento to bill to Medicare and MedicaidSAN DIEGO,…

Optimi Health Requests Final Inspection for Dealer’s License

3 years ago

VANCOUVER, British Columbia, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or…

SmileDirectClub Partners with Celebrity Cosmetic Dentist Dr. Amira Ogunleye To Advocate for Increased Access to Oral Care

3 years ago

Dr. Amira Ogunleye Dr. Amira Ogunleye, a celebrity cosmetic dentist and oral care thought leader, will partner with SmileDirectClub to…

Iovance Biotherapeutics to Present at Upcoming Conferences

3 years ago

SAN CARLOS, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel…

Skylight Health Announces Closing of Public Offering of 275,000 Shares of Series A Cumulative Redeemable Perpetual Preferred Stock

3 years ago

TORONTO, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG; TSXV: SLHG) (“Skylight Health” or the “Company”), a…

Innovative Inhaled Drug Delivery Developer Aerami Therapeutics to Merge with Special Purpose Acquisition Company FoxWayne Enterprises Acquisition Corp. to Become Public Company

3 years ago

New entity poised to accelerate the development of Aerami’s diverse pipeline ofnext-generation inhaled therapies AER-901, Aerami’s proprietary inhaled, nebulized formulation…